<p>(<b>A</b>) <i>ERK1</i>, <i>ERK2</i>, <i>p38</i>, and <i>JNK</i> mRNA expression after exposure of NP cells to PMA (0-200 nM) for 24 h assessed by real-time RT-PCR. (<b>B</b>) Western blot analysis of ERK and p38 activation following treatment of NP cells with PMA. After 1-day of serum deprivation, NP cells were treated with vehicle (control) or 200 nM PMA. The same blots were stripped and reprobed with antibodies for total and phosphorylated proteins of ERK or p38. β-actin was detected as a loading control. (<b>C</b>) NP cells were transfected with the c-fos reporter plasmid. The transfected cells were then treated with PMA with or without the MAPK inhibitors PD98059 (PD, 30 or 50 μM), SKF86002 (SKF, 5 or 20 μM), SB202190 (SB, 1 or 10 μM...
<p>A, HEK293 cells were serum starved for 5 hours followed by 100nM PMA for 2 min, 5 min, 10 min, 30...
<p>Microscopy of BEAS-2B cells after staining with 0.2 U/ml TRITC phalloidin for 40 min (n = 2). Cel...
<p>Cells were treated with PMA (0.1 µM), butyrate (2 mM) or both of them for 30 min and total protei...
<p>(<b>A</b>) Real-time RT-PCR analysis of PKCγ and PKCδ mRNA levels in NP cells treated with PMA (2...
<p>(<b>A</b>) c-fos was transfected with the pGL4.74 vector into NP cells, and the cells were stimul...
<p>MDA-MB231 cells were pretreated with a selective p38 MAPK inhibitor (SB203580, 5 µM) for 2 hours ...
(A, B, C) Cells were pretreated with 5 μM SB203580 (a p38 inhibitor), 5 μM SP600125 (a JNK inhibitor...
<p>MEFs (A) and HEK293 cells (B) were treated with TNF-α (20 ng/mL) or PMA (10 nM) for the indicated...
<p>(A,B) The cells were treated with PMBPs (0, 5, 10, 25 μg/ml) for 24 h. Cell lysates were prepared...
<p>MDA-MB231 cells were transfected with control siRNA or PKR siRNA for 48 h. <b>A</b>: Following tr...
(A) Cells were incubated with different doses of PMA for 24 h, and cytotoxicity was measured by cell...
<p>(A) Protein levels of phosphorylated ERK1/2 and total ERK1/2 were determined by western blot. SCi...
<p>PMNs were pretreated with ERK1/2 MAPK inhibitor U0126 or vehicle for 30 minutes, and then stimula...
(A, B) Human (late outgrowth) EPCs were pretreated with Gö6976 (a PKCα inhibitor), SB203580 (a p38 i...
<p>U937-SLC11A1 cells (stably expressing SLC11A1-c-Myc fusion protein) were left untreated or treate...
<p>A, HEK293 cells were serum starved for 5 hours followed by 100nM PMA for 2 min, 5 min, 10 min, 30...
<p>Microscopy of BEAS-2B cells after staining with 0.2 U/ml TRITC phalloidin for 40 min (n = 2). Cel...
<p>Cells were treated with PMA (0.1 µM), butyrate (2 mM) or both of them for 30 min and total protei...
<p>(<b>A</b>) Real-time RT-PCR analysis of PKCγ and PKCδ mRNA levels in NP cells treated with PMA (2...
<p>(<b>A</b>) c-fos was transfected with the pGL4.74 vector into NP cells, and the cells were stimul...
<p>MDA-MB231 cells were pretreated with a selective p38 MAPK inhibitor (SB203580, 5 µM) for 2 hours ...
(A, B, C) Cells were pretreated with 5 μM SB203580 (a p38 inhibitor), 5 μM SP600125 (a JNK inhibitor...
<p>MEFs (A) and HEK293 cells (B) were treated with TNF-α (20 ng/mL) or PMA (10 nM) for the indicated...
<p>(A,B) The cells were treated with PMBPs (0, 5, 10, 25 μg/ml) for 24 h. Cell lysates were prepared...
<p>MDA-MB231 cells were transfected with control siRNA or PKR siRNA for 48 h. <b>A</b>: Following tr...
(A) Cells were incubated with different doses of PMA for 24 h, and cytotoxicity was measured by cell...
<p>(A) Protein levels of phosphorylated ERK1/2 and total ERK1/2 were determined by western blot. SCi...
<p>PMNs were pretreated with ERK1/2 MAPK inhibitor U0126 or vehicle for 30 minutes, and then stimula...
(A, B) Human (late outgrowth) EPCs were pretreated with Gö6976 (a PKCα inhibitor), SB203580 (a p38 i...
<p>U937-SLC11A1 cells (stably expressing SLC11A1-c-Myc fusion protein) were left untreated or treate...
<p>A, HEK293 cells were serum starved for 5 hours followed by 100nM PMA for 2 min, 5 min, 10 min, 30...
<p>Microscopy of BEAS-2B cells after staining with 0.2 U/ml TRITC phalloidin for 40 min (n = 2). Cel...
<p>Cells were treated with PMA (0.1 µM), butyrate (2 mM) or both of them for 30 min and total protei...